دورية أكاديمية
Isolation and characterization of potential cancer stem cells from solid human tumors--potential applications.
العنوان: | Isolation and characterization of potential cancer stem cells from solid human tumors--potential applications. |
---|---|
المؤلفون: | Dobbin ZC; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama., Landen CN; Department of Obstetrics and Gynecology, Division of Gynecologic Oncology, University of Alabama at Birmingham, Birmingham, Alabama. |
المصدر: | Current protocols in pharmacology [Curr Protoc Pharmacol] 2013 Dec 02; Vol. 63, pp. 14.28.1-14.28.19. Date of Electronic Publication: 2013 Dec 02. |
نوع المنشور: | Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. |
اللغة: | English |
بيانات الدورية: | Country of Publication: United States NLM ID: 9717249 Publication Model: Electronic Cited Medium: Internet ISSN: 1934-8290 (Electronic) Linking ISSN: 19348282 NLM ISO Abbreviation: Curr Protoc Pharmacol Subsets: MEDLINE |
مواضيع طبية MeSH: | Neoplastic Stem Cells/*physiology , Tissue and Organ Harvesting/*methods, Animals ; Biological Assay/methods ; Biomarkers, Tumor/analysis ; Carcinogenicity Tests/methods ; Flow Cytometry/methods ; Heterografts/physiology ; Humans ; Indicators and Reagents/pharmacology ; Magnetic Fields ; Mice ; Neoplastic Stem Cells/cytology |
مستخلص: | Cancer stem cells (CSCs) are a subpopulation of cells within a heterogeneous tumor that have enhanced biologic properties, e.g., increased capacity for self-renewal, increased tumorigenicity, enhanced differentiation capacity, and resistance to chemo- and radiotherapies. This unit describes protocols to isolate and characterize potential cancer stem cells from a solid tumor. These involve creating a single-cell suspension from tumor tissue, tagging the cell subpopulations of interest, and sorting them into different populations. The sorted subpopulations can be evaluated for their ability to meet the functional requirements of a CSC, which primarily include increased tumorigenicity in an in vivo xenograft assay. Use of the protocols described in this unit makes it possible to study populations of cells that may have properties of CSCs. (Copyright © 2013 John Wiley & Sons, Inc.) |
References: | Dalerba, P. , Cho, R.W. , and Clarke, M.F. 2007a. Cancer stem cells: models and concepts. Annu. Rev. Med. 58:267-284. Dalerba, P. , Dylla, S.J. , Park, I.K. , Liu, R. , Wang, X. , Cho, R.W. , Hoey, T. , Gurney, A. , Huang, E.H. , Simeone, D.M. , Shelton, A.A. , Parmiani, G. , Castelli, C. , and Clarke, M.F. 2007b. Phenotypic characterization of human colorectal cancer stem cells. Proc. Natl. Acad. Sci. U.S.A. 104:10158-10163. Dontu, G. , Al-Hajj, M. , Abdallah, W.M. , Clarke, M.F. , and Wicha, M.S. 2003. Stem cells in normal breast development and breast cancer. Cell Proliferat. 36:59-72. Galli, R. , Binda, E. , Orfanelli, U. , Cipelletti, B. , Gritti, A. , De Vitis, S. , Fiocco, R. , Foroni, C. , Dimeco, F. , and Vescovi, A. 2004. Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011-7021. Goodell, M.A. 2005. Stem cell identification and sorting using the Hoechst 33342 side population (SP). Curr. Protoc. Cytom. 34:9.18.1-9.18.11. Goodell, M.A. , Brose, K. , Paradis, G. , Conner, A.S. , and Mulligan, R.C. 1996. Isolation and functional properties of murine hematopoietic stem cells that are replicating in vivo. J. Exp. Med. 183:1797-1806. Herzenberg, L.A. , Tung, J. , Moore, W.A. , Herzenberg, L.A. , and Parks, D.R. 2006. Interpreting flow cytometry data: A guide for the perplexed. Nat. Immunol. 7:681-685. Jordan, C.T. , Guzman, M.L. , and Noble, M. 2006. Cancer stem cells. N. Engl. J. Med. 355:1253-1261. Lapidot, T. , Sirard, C. , Vormoor, J. , Murdoch, B. , Hoang, T. , Caceres-Cortes, J. , Minden, M. , Paterson, B. , Caligiuri, M.A. , and Dick, J.E. 1994. A cell initiating human acute myeloid leukaemia after transplantation into SCID mice. Nature 367:645-648. O'Brien, C.A. , Pollett, A. , Gallinger, S. , and Dick, J.E. 2007. A human colon cancer cell capable of initiating tumour growth in immunodeficient mice. Nature 445:106-110. Petriz, J. 2013. Flow cytometry of the side population (SP). Curr. Protoc. Cytom. 64:9.23.1-9.23.20. Reynolds, B. and Weiss, S. 1992. Generation of neurons and astrocytes from isolated cells of the adult mammalian central nervous system. Science 255:1707-1710. Reynolds, B.A. and Weiss, S. 1996. Clonal and population analyses demonstrate that an EGF-responsive mammalian embryonic CNS precursor is a stem cell. Dev. Biol. 175:1-13. Robinson, J.P. , Darzynkiewicz, Z. , Dean, P.N. , Orfao, A. , Rabinovitch, P.S. , Stewart, C.C. Tanke, H.J. , and Wheeless, L.L. (eds.) 2013. Current Protocols in Cytometry. John Wiley & Sons, Hoboken, N.J. Siegel, R. , Naishadham, D. , and Jemal, A. 2012. Cancer statistics, 2012. CA Cancer J. Clin. 62:10-29. Singh, S.K. , Hawkins, C. , Clarke, I.D. , Squire, J.A. , Bayani, J. , Hide, T. , Henkelman, R.M. , Cusimano, M.D. , and Dirks, P.B. 2004. Identification of human brain tumour initiating cells. Nature 432:396-401. Steg, A.D. , Bevis, K.S. , Katre, A.A. , Ziebarth, A. , Dobbin, Z.C. , Alvarez, R.D. , Zhang, K. , Conner, M. , and Landen, C.N. 2012. Stem cell pathways contribute to clinical chemoresistance in ovarian cancer. Clin. Cancer Res. 18:869-881. Strober, W. 2001. Trypan blue exclusion test of cell viability. Curr. Protoc. Immunol. 21:A.3B.1-A.3B.2. Zhang, S. , Balch, C. , Chan, M.W. , Lai, H.C. , Matei, D. , Schilder, J.M. , Yan, P.S. , Huang, T.H. , and Nephew, K.P. 2008. Identification and characterization of ovarian cancer-initiating cells from primary human tumors. Cancer Res. 68:4311-4320. |
معلومات مُعتمدة: | K12 HD000849 United States HD NICHD NIH HHS; UL1 RR025777 United States RR NCRR NIH HHS; 5UL1RR025777 United States RR NCRR NIH HHS; K12 HD00849 United States HD NICHD NIH HHS |
فهرسة مساهمة: | Keywords: cancer stem cells; cell separation and sorting; xenograft assay |
المشرفين على المادة: | 0 (Biomarkers, Tumor) 0 (Indicators and Reagents) |
تواريخ الأحداث: | Date Created: 20140211 Date Completed: 20140926 Latest Revision: 20230105 |
رمز التحديث: | 20230105 |
مُعرف محوري في PubMed: | PMC4041697 |
DOI: | 10.1002/0471141755.ph1428s63 |
PMID: | 24510756 |
قاعدة البيانات: | MEDLINE |
تدمد: | 1934-8290 |
---|---|
DOI: | 10.1002/0471141755.ph1428s63 |